B

BioAI Paper Parser

2.85

Derivation Chain

Step 1 Rise of BioAI technologies including AI virtual cells and RNA therapeutics
Step 2 Growing paper and Patent analysis burden on BioAI researchers
Step 3 Tool to auto-extract key experimental conditions and results from BioAI papers into structured data

Problem

With KIST designating AI virtual cells and RNA therapeutics among its top 10 technologies, BioAI publications are surging (30%+ annual growth). Researchers at bio Startups and institutes spend 2–4 hours analyzing each paper, manually extracting and comparing key experimental conditions (cell lines, model architecture, dataset size, performance metrics). For researchers tracking 50–100 papers per month, this means 100+ hours of unproductive work monthly.

Solution

(1) Upload BioAI paper PDFs to auto-extract experimental conditions, results, and model specs into structured tables, (2) Auto-compare against existing extracted data to determine SOTA (State of the Art) update status, (3) Weekly arXiv/PubMed new paper alerts with keyword matching and summaries — delivered as a SaaS.

Target: BioAI Startup researchers (5–30 employees), graduate students and postdocs in university bioengineering and pharmaceutical research labs
Revenue Model: SaaS monthly flat rate of 49,000 KRW (~$37)/account (100 papers/month analysis), team plan 190,000 KRW (~$143)/month (5 accounts, unlimited), 50% discount for university research labs
Ecosystem Role: Infrastructure
MVP Estimate: 2_weeks

NUMR-V Scores

N Novelty
3.0/5
U Urgency
3.0/5
M Market
2.0/5
R Realizability
3.0/5
V Validation
3.0/5
NUMR-V Scoring System
N Novelty1-5How uncommon the service is in market context.
U Urgency1-5How urgently users need this problem solved now.
M Market1-5Market size and growth potential from proxy indicators.
R Realizability1-5Buildability for a small team with realistic constraints.
V Validation1-5Validation signal quality from competition and demand data.
SaaS N=.15 U=.20 M=.15 R=.30 V=.20 Senior N=.25 U=.25 M=.05 R=.30 V=.15

Feasibility (73%)

Tech Complexity
29.3/40
Data Availability
23.3/25
MVP Timeline
20.0/20
API Bonus
0.0/15
Feasibility Breakdown
Tech Complexity/ 40Difficulty of core implementation stack.
Data Availability/ 25Practical availability and cost of required data.
MVP Timeline/ 20Expected time to ship a usable MVP.
API Bonus/ 15Bonus for viable public API leverage.

Market Validation (51/100)

Competition
8.0/20
Market Demand
3.8/20
Timing
16.0/20
Revenue Signals
7.5/15
Pick-Axe Fit
10.5/15
Solo Buildability
5.0/10
Validation Breakdown
Competition/ 20Signal quality from competitor landscape.
Market Demand/ 20Demand proxies from search and mention patterns.
Timing/ 20Fit with current shifts in tech, behavior, and regulation.
Revenue Signals/ 15Reference evidence for monetization viability.
Pick-Axe Fit/ 15How well the concept serves participants in a trend.
Solo Buildability/ 10Practicality for lean-team implementation.

Technical Requirements

AI/ML [medium] Data Pipeline [medium] Frontend [low]
Dashboard